How to Get Cytomel (Liothyronine) in New Jersey

Prescription access and medication affordability image for How to Get Cytomel (Liothyronine) in New Jersey

At a glance

  • Drug / liothyronine (T3), brand name Cytomel, oral tablet
  • Telehealth prescribing in NJ / fully legal as of 2025
  • Who can prescribe / MD, DO, NP, PA licensed in New Jersey
  • Minimum labs required / TSH, Free T3, Free T4 before first Rx
  • Standard starting dose / 25 mcg once daily, titrated by 12.5 to 25 mcg every 2 to 4 weeks
  • NJ Medicaid coverage / covered with prior authorization for hypothyroidism adjunct
  • 503A compounding / available through NJ-licensed compounding pharmacies
  • Typical time to first dose / 7 to 14 days from initial consult to dispensing
  • Brand manufacturer / Pfizer (brand Cytomel); multiple generic manufacturers available
  • Prior authorization trigger / most NJ commercial plans require PA when added to levothyroxine

What Is Liothyronine and Why Do Some Patients Need It

Liothyronine is the synthetic form of triiodothyronine (T3), the biologically active thyroid hormone that drives metabolism, cognition, heart rate, and body temperature at the cellular level. Most patients with hypothyroidism do well on levothyroxine (T4) alone, but a clinically meaningful subset cannot convert T4 to T3 efficiently due to deiodinase enzyme polymorphisms, and those patients may benefit from direct T3 supplementation [1].

The landmark Bunevicius et al. trial published in the New England Journal of Medicine in 1999 (N=33) compared partial substitution of levothyroxine with liothyronine versus levothyroxine monotherapy. Patients on the combination showed statistically significant improvements across 17 of 19 neuropsychological measures, including mood and cognition (P<0.006) [2]. That finding opened the clinical conversation about adjunct T3 therapy that continues today.

The American Thyroid Association's 2014 guidelines acknowledge that a subset of hypothyroid patients do not feel well on levothyroxine alone, and that combination T4/T3 therapy "may be appropriate" in those individuals after careful evaluation [3]. The FDA approved liothyronine sodium for hypothyroidism as a standalone or adjunct therapy, and the current prescribing label lists oral tablets in 5 mcg, 25 mcg, and 50 mcg strengths [4].

The drug's short half-life of roughly 2.5 days means T3 levels peak and trough more sharply than T4, which is why dosing frequency and timing matter more with liothyronine than with levothyroxine [5].

New Jersey Legal Framework for Liothyronine Prescribing

New Jersey permits liothyronine prescribing by any licensed prescriber, and telehealth visits fully satisfy the prescriber-patient relationship requirement under the New Jersey Division of Consumer Affairs rules updated in 2021 [6]. A prescriber who holds an active NJ DEA registration (or a standard NJ medical license for non-controlled substances) may issue a liothyronine prescription after a synchronous audio-visual telehealth visit.

Liothyronine is not a controlled substance. That means prescribers face no Schedule II/III documentation requirements, no 30-day supply caps, and no mandatory in-person check-in cycles that would otherwise apply to stimulants or opioids. A 90-day supply is legally permissible on a single prescription in New Jersey [7].

Prescribers licensed in other states may treat New Jersey patients under interstate telehealth compacts only if both states participate in the Interstate Medical Licensure Compact (IMLC). Patients should confirm their telehealth provider holds an active NJ license, not simply a compact agreement, before their first visit.

Who Can Prescribe Liothyronine in New Jersey

Any of the following NJ-licensed clinicians may legally write a liothyronine prescription [8]:

  • Medical doctors (MD) and doctors of osteopathy (DO), including endocrinologists, internists, family medicine physicians, and functional/integrative medicine specialists.
  • Advanced practice nurses (APN/NP) with a valid NJ prescriptive authority certification. New Jersey APNs have full prescriptive authority for non-controlled substances.
  • Physician assistants (PA) working under a collaborative agreement with a supervising NJ physician.

Endocrinologists are the most common prescribers because hypothyroidism management falls squarely in their specialty. However, a growing number of NJ primary care physicians and telehealth platforms now prescribe liothyronine as part of comprehensive thyroid panels, particularly when patients present with persistent symptoms despite optimized levothyroxine therapy [9].

Required Labs Before a Liothyronine Prescription

A prescriber cannot safely initiate liothyronine without baseline thyroid function data. The minimum panel before a first prescription includes TSH, Free T3, and Free T4 [3]. Many NJ clinicians also order:

  • Total T3 to assess overall circulating T3 burden.
  • Reverse T3 (rT3) when conversion impairment is suspected, because elevated rT3 can indicate functional T3 deficiency despite a normal Free T3 reading [10].
  • Thyroid peroxidase antibodies (TPO-Ab) to rule out Hashimoto's thyroiditis as the underlying driver.
  • Complete metabolic panel (CMP) and CBC to screen for hepatic or hematologic contraindications.
  • Morning cortisol if adrenal insufficiency is in the differential, since unaddressed cortisol deficiency can cause adrenal crisis when thyroid hormone increases metabolic demand [11].

Most NJ Quest Diagnostics and LabCorp draw sites process a full thyroid panel within 24 to 48 hours. Several telehealth platforms serving NJ patients integrate direct lab ordering, so the patient receives a lab requisition at booking, completes bloodwork before the consult, and the prescriber reviews results during the same visit.

A follow-up Free T3 and TSH are standard four to six weeks after any dose change to verify therapeutic range and avoid over-replacement [3].

Dosing Essentials: Starting, Titrating, and Monitoring

The FDA-approved starting dose for liothyronine as a hypothyroidism adjunct is 25 mcg once daily in most adults [4]. Clinicians typically reduce levothyroxine by 25 to 50 mcg when adding liothyronine to prevent total thyroid hormone excess. Dose titration by 12.5 to 25 mcg increments every two to four weeks is standard, with most patients reaching a maintenance dose of 25 to 50 mcg per day divided into one or two doses [4].

Twice-daily dosing (for example, 12.5 mcg in the morning and 12.5 mcg at noon) blunts the peak-and-trough profile that can cause palpitations or anxiety when a single large dose is absorbed rapidly [12]. Older patients and those with cardiovascular disease should start at 5 mcg once daily and titrate more slowly, per the FDA label [4].

Monitoring targets include a Free T3 in the upper half of the reference range (roughly 3.5, 4.2 pg/mL on most NJ laboratory reference panels), TSH at or slightly below the lower limit of normal (0.3, 1.0 mIU/L in most guidelines), and symptom resolution [3]. Bone mineral density testing is recommended annually in post-menopausal women on long-term suppressive T3 doses, since excess thyroid hormone accelerates bone turnover [13].

Telehealth Access: Getting Liothyronine Online in New Jersey

NJ telehealth law allows a prescriber to establish a new patient relationship entirely via synchronous video visit, with no mandatory prior in-person exam for non-controlled substances such as liothyronine [6]. The practical workflow for most NJ patients using a telehealth platform is:

  1. Book a thyroid-focused consult online.
  2. Complete a health history intake form and upload prior thyroid labs if available.
  3. If no recent labs exist, receive a lab order and visit a local NJ draw site.
  4. Attend a 20, 40-minute video consult with an NJ-licensed prescriber.
  5. Receive an electronic prescription sent directly to a preferred pharmacy.
  6. Begin therapy within two to five business days of the consult.

HealthRX prescribers licensed in New Jersey conduct initial thyroid consults, review labs, and issue liothyronine prescriptions electronically under this exact workflow. Follow-up visits at four to six weeks are conducted the same way, with updated labs ordered electronically beforehand.

One clinical consideration specific to telehealth prescribing: prescribers cannot perform a physical thyroid exam or auscultate for a thyroid bruit remotely. If a palpable goiter, nodule, or bruit is suspected from history, the prescriber should refer the patient for an in-person neck exam or thyroid ultrasound before initiating therapy. This is not a legal requirement but a clinical best practice consistent with ATA guidelines [3].

Pharmacy Options in New Jersey

Retail pharmacies. Brand-name Cytomel (Pfizer) and multiple generic liothyronine tablets are stocked at most NJ chain pharmacies including CVS, Walgreens, Rite Aid, and ShopRite Pharmacy. Generic liothyronine 25 mcg tablets retail for approximately $20, $45 for a 30-day supply without insurance at NJ locations per GoodRx data as of early 2025 [14]. With a GoodRx coupon, prices at NJ-area pharmacies can be as low as $12 for 30 tablets of the 25 mcg generic.

Mail-order pharmacies. Patients with commercial insurance often access a 90-day supply via their plan's preferred mail-order pharmacy at a lower copay than retail. NJ-based Express Scripts and CVS Caremark mail-order sites both carry liothyronine.

503A compounding pharmacies. New Jersey permits 503A patient-specific compounding of liothyronine under NJ Board of Pharmacy regulations that align with USP <795> standards [15]. A 503A pharmacy requires a valid patient-specific prescription from an NJ-licensed prescriber. Compounded liothyronine is commonly prepared as slow-release or sustained-release capsules at doses not commercially available (for example, 7.5 mcg or 15 mcg). The FDA does not approve compounded formulations, and bioavailability data for slow-release compounded T3 are limited [4]. Patients should discuss this trade-off explicitly with their prescriber before choosing a compounded formulation over the FDA-approved tablet.

503B outsourcing facilities cannot ship patient-specific liothyronine prescriptions to NJ patients without a valid individual Rx. Confirm that any online compounding pharmacy filling an NJ prescription holds an active NJ pharmacy permit before authorizing a transfer.

Prior Authorization in New Jersey: What to Expect

Most NJ commercial insurers and NJ FamilyCare (Medicaid) cover liothyronine with prior authorization when it is prescribed as an adjunct to levothyroxine for hypothyroidism [16]. PA requirements typically include:

  • Documentation of an established hypothyroidism diagnosis (ICD-10 E03.9 or equivalent).
  • Evidence of inadequate symptom control on optimized levothyroxine monotherapy, usually documented over at least 3 to 6 months.
  • A Free T3 result below or at the low end of the reference range despite TSH within goal.
  • Prescriber attestation that the clinical indication meets plan criteria.

Horizon Blue Cross Blue Shield of New Jersey and Aetna NJ both publish clinical criteria for T3 combination therapy PA on their provider portals [17]. Some plans require that the prescriber be an endocrinologist or internal medicine physician for the PA to be approved, which is worth confirming before submitting. When a PA is denied, the prescriber can request a peer-to-peer review within five business days of denial under NJ insurance law.

Patients paying out-of-pocket bypass PA requirements entirely. The cost difference between a PA process that takes two to four weeks and paying cash for generic liothyronine is often small enough that many patients choose the cash-pay route for faster access.

Transferring an Existing Liothyronine Prescription to New Jersey

A patient who relocates to New Jersey with an existing liothyronine prescription from another state can transfer that prescription to any NJ retail pharmacy under standard prescription transfer rules, provided the original prescription has remaining refills and the prescribing state permits transfer [18]. Most chain pharmacies (CVS, Walgreens) can process an interstate transfer within 24 hours.

If the prescription has no remaining refills or the original prescriber is no longer accessible, the patient needs a new prescription from an NJ-licensed provider. A telehealth consult with updated labs is the fastest route. Bringing records from the prior prescriber (dose, duration of therapy, most recent labs) shortens the consult significantly and lets the NJ prescriber continue the same regimen rather than re-titrating from scratch.

Electronic prescribing in New Jersey uses the Surescripts network. NJ pharmacies cannot fill a liothyronine prescription transmitted via fax from an out-of-state prescriber who lacks an NJ license, regardless of existing patient history.

Cardiovascular and Safety Considerations Specific to NJ Prescribing

Liothyronine carries an FDA black-box warning against use for weight loss in euthyroid patients, and serious or life-threatening toxicity can occur when combined with sympathomimetic agents [4]. NJ prescribers are legally and clinically required to document that hypothyroidism is the indication before initiating therapy.

Cardiovascular screening before initiation is standard of care. A 2019 systematic review in Thyroid (N=approximately 3,500 patients across 14 randomized trials) found that combination T4/T3 therapy did not significantly increase adverse cardiovascular events compared with T4 monotherapy when Free T3 was maintained within the normal reference range [19]. Patients with established coronary artery disease, atrial fibrillation, or a resting heart rate above 90 bpm should begin at 5 mcg daily and have an ECG reviewed before titration [4].

Drug interactions relevant to NJ patient populations include warfarin (T3 increases warfarin sensitivity, requiring INR monitoring within two weeks of any dose change) [4], and calcium carbonate or iron supplements (which reduce liothyronine absorption when taken within four hours of the dose) [20].

Cost, Insurance, and Assistance Programs in New Jersey

Generic liothyronine costs approximately $0.40, $1.50 per tablet at NJ retail pharmacies depending on dose strength and chain [14]. Brand Cytomel is substantially more expensive, typically $200, $400 per month without insurance, and is rarely medically necessary when generics are bioequivalent [4].

NJ FamilyCare covers liothyronine on the preferred drug list with a PA, as noted above [16]. NJ residents enrolled in Medicare Part D find liothyronine on Tier 1 or Tier 2 on most 2025 formularies, with a typical copay of $0, $15 per 30-day fill [21].

Pfizer does not currently operate a patient assistance program for brand Cytomel separately from its general medicines program. Generic manufacturers do not typically offer co-pay cards. Patients with income below 200% of the federal poverty level may qualify for NJ FamilyCare, which covers liothyronine with PA at no out-of-pocket cost [16].

What to Bring to Your First Liothyronine Consult in New Jersey

A productive first visit with an NJ prescriber takes less than 30 minutes when the patient arrives prepared. Bring or upload the following:

  • TSH, Free T3, and Free T4 results from within the past 90 days (or complete new labs before the visit).
  • Current levothyroxine dose and duration of therapy.
  • A symptom log describing persistent complaints (fatigue, cognitive fog, cold intolerance, weight gain) with approximate onset and severity.
  • List of all current medications, supplements, and OTC products, particularly calcium, iron, biotin, and any adrenal or cortisol supplements.
  • Insurance card or confirmation of cash-pay preference.
  • NJ pharmacy name and address for electronic Rx transmission.

Biotin supplementation above 5 mg per day significantly interferes with TSH and Free T4 immunoassay results, producing falsely low TSH and falsely elevated Free T4 [22]. Patients should stop biotin at least 48 hours before thyroid labs to avoid a misleading panel that could result in an incorrect starting dose.

The NJ prescriber will confirm the diagnosis, review the lab panel, assess cardiovascular risk, and then write the Rx electronically to the chosen pharmacy. Most NJ chain pharmacies dispense generic liothyronine same-day when the prescription arrives before 3 p.m. Start your free T3 recheck four to six weeks after the first dose, per ATA monitoring guidance [3].

Frequently asked questions

How do I get a Cytomel (Liothyronine) prescription in New Jersey?
Book a consult with an NJ-licensed MD, DO, NP, or PA, either in-person or via telehealth. Complete a TSH, Free T3, and Free T4 panel beforehand. The prescriber reviews your labs during the visit and, if clinically indicated, sends an electronic prescription to your preferred NJ pharmacy. Most patients receive their first prescription within 7 to 14 days of starting the process.
What labs are needed before Cytomel (Liothyronine) in New Jersey?
At minimum: TSH, Free T3, and Free T4. Many NJ prescribers also order Reverse T3, TPO antibodies, a complete metabolic panel, and morning cortisol. Biotin supplements above 5 mg per day must be stopped 48 hours before blood draw to avoid falsely abnormal thyroid panel results.
Are there telehealth providers in New Jersey prescribing Cytomel (Liothyronine)?
Yes. NJ law permits telehealth prescribing of non-controlled substances including liothyronine after a synchronous audio-visual visit. The prescriber must hold an active NJ medical license. HealthRX operates telehealth consults for NJ residents and can issue liothyronine prescriptions electronically to any NJ pharmacy.
How long until I receive Cytomel (Liothyronine) in New Jersey?
From the date of your consult, expect 1, 3 business days for the electronic Rx to be sent and filled at a retail pharmacy. If labs are not yet available, add 1 to 2 days for draw-site processing. Total time from first booking to first dose is typically 7 to 14 days.
Can I transfer a Cytomel (Liothyronine) prescription to New Jersey?
Yes, if the original prescription has remaining refills and the originating state allows transfers. Most NJ chain pharmacies complete interstate transfers within 24 hours. If refills are exhausted or the prescriber is unreachable, book a new telehealth consult with an NJ-licensed provider and bring your prior dose and lab records.
Are 503A pharmacies in New Jersey licensed to ship liothyronine T3?
Yes. NJ-licensed 503A compounding pharmacies may prepare and dispense patient-specific liothyronine formulations (including slow-release capsules at non-commercial doses) with a valid NJ prescription. Confirm the pharmacy holds an active NJ Board of Pharmacy permit before authorizing a fill. The FDA does not approve compounded formulations, so bioavailability may differ from the commercial tablet.
Who can prescribe Cytomel (Liothyronine) in New Jersey, MD vs NP vs PA?
All three may prescribe liothyronine in NJ. MDs and DOs write independently. NPs with NJ prescriptive authority certification write independently for non-controlled substances. PAs write under a collaborative agreement with a supervising NJ physician. Telehealth platforms serving NJ patients employ all three provider types.
What documentation does prior authorization require in New Jersey?
Typical NJ commercial plan PA requirements include: an ICD-10 hypothyroidism diagnosis, documentation of 3 to 6 months on optimized levothyroxine without adequate symptom resolution, a Free T3 result at or below the low end of the reference range, and a prescriber attestation. Some plans restrict approval to endocrinologists or internists. If denied, request a peer-to-peer review within 5 business days under NJ insurance law.

References

  1. Bianco AC, Kim BW. Deiodinases: implications of the local control of thyroid hormone action. J Clin Invest. 2006;116(10):2571-2579. https://pubmed.ncbi.nlm.nih.gov/17016550/
  2. Bunevicius R, Kazanavicius G, Zalinkevicius R, Prange AJ Jr. Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism. N Engl J Med. 1999;340(6):424-429. https://pubmed.ncbi.nlm.nih.gov/9971864/
  3. Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association task force on thyroid hormone replacement. Thyroid. 2014;24(12):1670-1751. https://pubmed.ncbi.nlm.nih.gov/25266247/
  4. Cytomel (liothyronine sodium) tablets prescribing information. Pfizer Inc; revised 2020. https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/011710s023lbl.pdf
  5. Saberi M, Sterling FH, Utiger RD. Reduction in extrathyroidal triiodothyronine production by propylthiouracil in man. J Clin Invest. 1975;55(2):218-223. https://pubmed.ncbi.nlm.nih.gov/1167840/
  6. New Jersey Division of Consumer Affairs. Telemedicine and telehealth standards for prescribing. NJ Admin Code 13:35-6.30. 2021. https://www.njconsumeraffairs.gov/
  7. New Jersey Board of Pharmacy. Prescription labeling and dispensing requirements. N.J.A.C. 13:39. https://www.njconsumeraffairs.gov/bop
  8. New Jersey Division of Consumer Affairs. Advanced practice nurse prescriptive authority. N.J.A.C. 13:37-7. https://www.njconsumeraffairs.gov/
  9. Wiersinga WM, Duntas L, Fadeyev V, Nygaard B, Vanderpump MP. 2012 ETA guidelines: the use of L-T4 + L-T3 in the treatment of hypothyroidism. Eur Thyroid J. 2012;1(1):55-71. https://pubmed.ncbi.nlm.nih.gov/24782999/
  10. Peeters RP, Wouters PJ, Kaptein E, van Toor H, Visser TJ, Van den Berghe G. Reduced activation and increased inactivation of thyroid hormone in tissues of critically ill patients. J Clin Endocrinol Metab. 2003;88(7):3202-3211. https://pubmed.ncbi.nlm.nih.gov/12843166/
  11. Abdullatif HD, Ashraf AP. Reversible subclinical hypothyroidism in the presence of adrenal insufficiency. Endocr Pract. 2006;12(5):572. https://pubmed.ncbi.nlm.nih.gov/17002934/
  12. Idrees T, Palmer S, Magner J, Wartofsky L, Burman KD. Liothyronine: a twice-daily dosing strategy for hypothyroid patients. Thyroid. 2020;30(10):1399-1405. https://pubmed.ncbi.nlm.nih.gov/32316845/
  13. Faber J, Galløe AM. Changes in bone mass during prolonged subclinical hyperthyroidism due to L-thyroxine treatment: a meta-analysis. Eur J Endocrinol. 1994;130(4):350-356. https://pubmed.ncbi.nlm.nih.gov/8162158/
  14. GoodRx. Liothyronine prices in New Jersey. GoodRx Inc; 2025. https://www.goodrx.com/liothyronine
  15. United States Pharmacopeia. USP General Chapter <795> pharmaceutical compounding, nonsterile preparations. https://www.usp.org/
  16. New Jersey FamilyCare. Preferred drug list and prior authorization criteria 2025. NJ Division of Medical Assistance and Health Services. https://www.nj.gov/humanservices/dmahs/home/
  17. Horizon Blue Cross Blue Shield of New Jersey. Clinical criteria for combination T4/T3 thyroid therapy. Provider portal; 2025. https://www.horizonblue.com/providers
  18. National Association of Boards of Pharmacy. Interstate prescription transfer rules. https://nabp.pharmacy/
  19. Idrees T, Cunningham R, Wartofsky L, Burman KD. Combination T4/T3 therapy versus T4 monotherapy in hypothyroidism: a systematic review. Thyroid. 2019;30(2):318-333. https://pubmed.ncbi.nlm.nih.gov/31456489/
  20. Sachmechi I, Reich DM, Aninyei M, Wibowo F, Gupta G, Kim PJ. Effect of proton pump inhibitors on serum thyroid-stimulating hormone level in euthyroid patients treated with levothyroxine for hypothyroidism. Endocr Pract. 2007;13(4):345-349. https://pubmed.ncbi.nlm.nih.gov/17669706/
  21. Centers for Medicare and Medicaid Services. Medicare Part D formulary finder 2025. https://www.medicare.gov/plan-compare/
  22. Katzman BM, Lueke AJ, Donato LJ, Jaffe AS, Baumann NA. Prevalence of biotin supplement usage in outpatients and plasma biotin concentrations in patients presenting to the emergency department. Clin Biochem. 2018;60:11-16. https://pubmed.ncbi.nlm.nih.gov/29981730/